
Medicross Pharma-Chem Limited
Pharmaceutical and medical goods trading company since 1996.
Pharmaceutical and medical goods trading company since 1996.
Medicross Pharma-Chem Limited (MPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 30 September 1996 and has a history of 28 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.60 M.
The company currently has active open charges totaling ₹0.20 M.
Anu Dewan, Tariq Masood, Sakshi Bhardwaj, and Three other members serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U24231DL1996PLC082346
082346
Public Limited Indian Non-Government Company
30 Sep 1996
30 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Tariq Masood ![]() | Whole-Time Director | 26-Mar-2015 | Current |
Sakshi Bhardwaj ![]() | Director | 15-Mar-2017 | Current |
Anirudh Bhardwaj ![]() | Director | 15-Mar-2017 | Current |
Anu Dewan ![]() | Whole-Time Director | 26-Mar-2015 | Current |
Prateek Dewan ![]() | Whole-Time Director | 01-Jan-2023 | Current |
Arif Masood ![]() | Whole-Time Director | 30-Sep-1996 | Current |
Medicross Pharma-Chem Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.63% increase. The company also saw a substantial fall in profitability, with a 57.85% decrease in profit. The company's net worth moved up by a moderate rise of 5.59%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Medicross Pharma-Chem had a promoter holding of 81.50% and a public holding of 18.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹0.20 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
15 Mar 1991 | Canara Bank | ₹0.20 M | Open |
Unlock and access historical data on people associated with Medicross Pharma-Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medicross Pharma-Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicross Pharma-Chem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medicross Pharma-Chem Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Medicross Pharma-Chem Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Sakshi Bhardwaj was appointed as a Director was appointed as a Director on 15 Mar 2017 & has been associated with this company since 8 years 2 months .
Anirudh Bhardwaj was appointed as a Director was appointed as a Director on 15 Mar 2017 & has been associated with this company since 8 years 2 months .
Anu Dewan was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 26 Mar 2015 & has been associated with this company since 10 years 2 months .
Tariq Masood was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 26 Mar 2015 & has been associated with this company since 10 years 2 months .
Medicross Pharma-Chem Limited was incorporated on 30 Sep 1996.
The authorized share capital of Medicross Pharma-Chem Limited is ₹ 3.00 M and paid-up capital is ₹ 1.60 M.
Currently 6 directors are associated with Medicross Pharma-Chem Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Medicross Pharma-Chem Limited is F-60 Azad Apartments Plot No. 111 I.P. Extension, India, Delhi, 110092.
The corporate identification number (CIN) of Medicross Pharma-Chem Limited is U24231DL1996PLC082346 and the company number is 082346 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Medicross Pharma-Chem Limited has risen by 9.63%.
The financial reports for the fiscal year 2023 indicates that The net worth of Medicross Pharma-Chem Limited has experienced an upsurge of 5.59%.
As per the financial statements for fiscal Year 2023, The total open charges for Medicross Pharma-Chem Limited amount to ₹ 0.20 M.
The most recent Balance Sheet for Medicross Pharma-Chem Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
RB
ND